In this mini-review from 1999, the author summarizes current knowledge of the bioinorganic chemistry of vanadium, the basic features of diabetes mellitus and its metabolic sequelae, and the in vitro and in vivo effects of both inorganic and organically chelated vanadium compounds. Clinical trials to that point, as well as kinetic studies of tissue uptake, are also covered.
References:
Thompson KH. Vanadium and diabetes. Biofactors. 1999;10(1):43-51. doi: 10.1002/biof.5520100105. PMID: 10475589.